Functional status and life satisfaction of patients with stable angina pectoris in Austria

Author:

Spinka Fabian,Aichinger Josef,Wallner Eva,Brecht Stephan,Rabold Thomas,Metzler Bernhard,Zweiker Robert,Lang Irene,Delle Karth Georg

Abstract

ObjectivesAlthough substantial progress in the treatment of stable angina pectoris (sAP) has been made, little is known about the functional status and quality of life (QoL) of patients in different healthcare systems.Design and methodsWe undertook a survey using the Seattle Angina Questionnaire (SAQ) (five domains scored form 0—worst assessment to 100—best assessment) to assess symptoms, QoL (including limitation of activities), demographics, geographic distribution and individual disease data in patients with stable coronary artery disease in Austrian cardiology practices.ResultsA total of 660 patients with sAP with a mean age of 69.2 years were included. SAQ scores were 67.5±24.4 for physical limitation, 65.5±26.6 for angina stability, 79.3±23.2 for angina frequency, 86.3±16.2 for treatment satisfaction and 63.7±24.2 for overall QoL. Multiple regression identified male gender, but also female gender, Eastern Austrian residence and high body mass index as predictive factors for SAQ scoring. A total of 35.6% of the patients reported at least one desirable activity that was limited through AP symptoms.ConclusionsActivity and QoL assessments are in accordance with published literature: The number and the diversity of desired activities indicate the need to focus on patient’s individual activity level to improve symptom management.

Funder

A Menarini Pharma GmbH

Publisher

BMJ

Subject

General Medicine

Reference26 articles.

1. World Health Organization (WHO) . Cardiovascular diseases (CVDs) 2017, 2017. Available: http://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) [Accessed 19 Nov 2018].

2. Optimal Medical Therapy with or without PCI for Stable Coronary Disease

3. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial;Al-Lamee;The Lancet,2018

4. Bischoff M . Ranolazin lindert ischämiebedingte Beschwerden. Jatros Kardiologie und Gefäßmedizin 2017;2017.

5. Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Achieving Cardiovascular Risk Management Goals and Patient Quality of Life;Journal of Cardiovascular Development and Disease;2024-01-31

2. Acupuncture on treating angina pectoris;Medicine;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3